Tonix Pharmaceuticals Unveils TONIX-ONE: A Comprehensive Digital Platform Empowering Migraine Patients to Take Charge of Their Condition
Revolutionizing Migraine Management: Tonix Pharmaceuticals Introduces TONIX ONE™ In an era where digital health solutions are increasingly becoming the norm, Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a pioneering biopharmaceutical company, has taken a significant step forward in the migraine community. On April 1, 2025, Tonix Pharmaceuticals announced the launch of TONIX ONE™, a comprehensive digital…